BIONET Therapeutics Corp. (TPEX:7808)
Taiwan · Delayed Price · Currency is TWD 42.80
-0.20 (-0.47%)
At close: Mar 27, 2026
BIONET Therapeutics Market Cap
BIONET Therapeutics has a market cap or net worth of 3 billion as of March 27, 2026. Its market cap has decreased by -25.95% in one year.
Market Cap
3.00B
Enterprise Value
1.86B
Revenue
105.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
42.80
Market Cap Chart
Since December 12, 2024, BIONET Therapeutics's market cap has decreased from 3.82B to 3.00B, a decrease of -21.47%. That is a compound annual growth rate of -17.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 3.00B | -23.84% |
| Dec 31, 2025 | 3.93B | 20.99% |
| Dec 31, 2024 | 3.25B | -14.77% |
| Dec 12, 2024 | 3.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Minson Integration | 3.03B |
| Young Shine Electric | 3.03B |
| SysJust | 3.03B |
| Taiwan Takisawa Technology | 3.02B |
| Chip Hope | 3.00B |
| Gold Rain Enterprises | 3.00B |
| Syngen Biotech | 2.98B |
| Ampire | 2.97B |